Posts

Non-reproducible prior art post-G 1/23: Novelty versus inventive step (T 1044/23)

Fire sale of BMWs backfires: Hague court rejects exhaustion defence

EPO pharma case law trends 2025: Antibodies and biologics

Can infringement be avoided by performing part of a diagnostic method claim in another jurisdiction?

Sunday Surprises

Best-case scenario for Puma?

[Guest Book Review] Publishers’ Rights and Copyright Law

Freedom of expression is only "due cause" if targeted at the trade mark holder, says Advocate General in IKEA-PLAN opinion

Never Too Late: If you missed the IPKat last week!

Why you still can't have your cake and eat it too: "best method" lives on in Australia